CliffBio
small molecule

PIPRACIL

PIPERACILLIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand namePIPRACIL
Active ingredientPIPERACILLIN SODIUM
StrengthEQ 2GM BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 1987
Marketing statusDISCN

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.